Showing 181 - 200 results of 365 for search '"RTI International"', query time: 0.11s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189

    Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping by Ray SE, Boudewyns V, Davis C, Tzeng JP, Srivastava I, Oguntimein O, Conti DS, Feibus KB

    Published 2022-08-01
    “…Sarah E Ray,1 Vanessa Boudewyns,1 Christine Davis,1 Janice P Tzeng,1 Ila Srivastava,2 Oluwamurewa Oguntimein,3 Denise S Conti,4 Karen B Feibus2 1Center for Communication Science, RTI International, Research Triangle Park, NC, USA; 2Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; 3Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA; 4Office of Safety and Clinical Evaluation, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USACorrespondence: Sarah E Ray, Center for Communication Science, RTI International, Research Triangle Park, NC, USA, Tel +1 770-407-4934, Email sray@rti.orgPurpose: This qualitative study explored patients’ attitudes about and perceptions of generic dry powder inhaler (DPI) substitution for the brand product and patients’ views of generic product quality, efficacy, design, and usability.Methods: Forty COPD and asthma patients (36 adults, four adolescents), who were actively using a brand DPI product, participated in one of six focus groups. …”
    Get full text
    Article
  10. 190
  11. 191
  12. 192
  13. 193
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200